8-KMaterial AgreementsShareholder MattersCorporate Changes+2

WILLIAMS COMPANIES, INC. 8-K Report, Material Agreement (Mar 20, 2020)

Filed March 20, 2020For Securities:WMB

Summary

Williams Companies, Inc. (WMB) has filed an 8-K to announce the adoption of a limited duration stockholder rights plan, also known as a 'poison pill'. Effective March 19, 2020, a dividend of one preferred stock purchase right was declared for each outstanding share of common stock. These rights are designed to deter hostile takeovers by imposing a significant penalty on any entity that acquires 5% or more of the company's stock without board approval. The rights will become exercisable under specific conditions, primarily triggered by an 'Acquiring Person' exceeding the 5% ownership threshold, leading to potential dilution for that acquirer and benefits for other shareholders. This move by the Board of Directors aims to protect shareholders by ensuring that any potential acquirer would need to negotiate with the Board and pay a fair premium for control of the company. The rights will expire one year from the adoption date unless redeemed or otherwise terminated. This filing also includes the establishment of Series C Participating Cumulative Preferred Stock, which is linked to the rights plan.

Key Highlights

  • 1Williams Companies adopted a stockholder rights plan (poison pill) effective March 19, 2020.
  • 2A dividend of one preferred stock purchase right was issued for each outstanding share of common stock.
  • 3The rights are designed to prevent hostile takeovers by imposing a penalty on entities acquiring 5% or more of the stock without board approval.
  • 4The rights will become exercisable if an 'Acquiring Person' (beneficial owner of 5% or more stock) emerges.
  • 5Upon triggering, the rights allow other shareholders to purchase Williams' stock at a discount or the company's preferred stock.
  • 6The plan aims to ensure any takeover attempt involves fair negotiation and a premium for shareholders.
  • 7The rights expire on the first anniversary of the agreement unless redeemed or terminated earlier.

Frequently Asked Questions

A stockholder rights plan, commonly known as a 'poison pill', is a defensive strategy adopted by a company's board of directors to prevent hostile takeovers. Williams Companies adopted this plan to reduce the likelihood of a potential acquirer gaining control of the company without paying an appropriate premium for its shares. It discourages open market accumulation or other tactics that could lead to a change in control without board approval.

The rights were declared on March 19, 2020, and are payable to shareholders of record on March 30, 2020. However, the rights are not exercisable until the 'Distribution Date', which is generally triggered by the emergence of an 'Acquiring Person' (someone who acquires 5% or more of the common stock without board approval) or the commencement of a tender offer that would result in such ownership.

If a person or group becomes an 'Acquiring Person' (acquires 5% or more of the stock without board approval), the rights held by all other shareholders (excluding the Acquiring Person) will become exercisable. This typically allows them to purchase Williams' common stock at a significant discount to its market value (a 'flip-in' event), or, in the event of a merger or sale of assets, to purchase stock in the acquiring entity (a 'flip-over' event). These provisions are designed to make a hostile takeover prohibitively expensive.

Yes, the Board of Directors has the right to redeem all of the rights at a nominal price per right ($0.001) at any time before an 'Acquiring Person' emerges. Additionally, the rights have an expiration date, which is the first anniversary of the rights agreement, unless earlier exercised, exchanged, amended, or redeemed.